Cingulate Inc. (CING)
NASDAQ: CING · Real-Time Price · USD
3.910
-0.010 (-0.26%)
At close: Dec 9, 2025, 4:00 PM EST
3.840
-0.070 (-1.79%)
After-hours: Dec 9, 2025, 7:28 PM EST
Cingulate Market Cap
Cingulate has a market cap or net worth of $26.42 million as of December 9, 2025. Its market cap has increased by 76.88% in one year.
Market Cap
26.42M
Enterprise Value
24.88M
1-Year Change
76.88%
Ranking
Category
Stock Price
$3.91
Market Cap Chart
Since the IPO on December 8, 2021, Cingulate's market cap has decreased from $64.29M to $26.42M, a decrease of -58.90%. That is a compound annual growth rate of -19.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 26.42M | 62.30% |
| Dec 31, 2024 | 16.28M | 127.09% |
| Dec 29, 2023 | 7.17M | -36.62% |
| Dec 30, 2022 | 11.31M | -63.77% |
| Dec 31, 2021 | 31.21M | -51.44% |
| Dec 8, 2021 | 64.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 893.23B |
| Johnson & Johnson | 485.76B |
| AbbVie | 394.34B |
| UnitedHealth Group | 293.15B |
| AstraZeneca | 280.30B |
| Novartis AG | 253.21B |
| Merck & Co. | 245.55B |
| Thermo Fisher Scientific | 213.48B |